Myasthenia gravis: vizsgálatok itt: Kína
43 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Jinan, Nanchang, Qingdao, Shijiazhuang
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341 - Korai 1. fázisNot yet taking people in KínaUniversal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 15
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT07392528 - No phaseTaking peopleTheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Tang-Du Hospital
See details and how to joinNCT04182984 - No phaseNot yet taking people in KínaTongji NADs Cohort
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 1550
- Run by
- Tongji Hospital
See details and how to joinNCT07333196 - Korai 1. fázisTaking peopleUniversal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT06939166 - 3. fázisNot yet taking people in KínaEFG vs IVIG in TAMG
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 64
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07231523 - 1. fázisTaking peopleSafety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
- Where
- Xi’an
- Életkor
- 18 év to 80 év
- People
- 9
- Run by
- Ting Chang, MD
See details and how to joinNCT06371040 - Korai 1. fázisTaking peopleGC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Daishi Tian
See details and how to joinNCT07058298 - No phaseTaking peopleConstruction of A Multimodal Digital Assessment Model for Myasthenia Gravis
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 180
- Run by
- Huashan Hospital
See details and how to joinNCT07146425 - 1. fázisTaking peopleA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- RenJi Hospital
See details and how to joinNCT06249438 - No phaseTaking peoplePrecision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
- Where
- Shanghai
- Életkor
- 0 év to 90 év
- People
- 500
- Run by
- Huashan Hospital
See details and how to joinNCT04535843 - 1. fázisNot yet taking people in KínaUCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
- Where
- Changzhou
- Életkor
- 18 év and over
- People
- 18
- Run by
- Changzhou No.2 People's Hospital
See details and how to joinNCT06978738 - 2. fázisTaking peopleEfficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
- Where
- Beijing, Changsha, Chengdu, Shanghai, Tianjin, Xi’an
- Életkor
- 18 év to 80 év
- People
- 64
- Run by
- Tang-Du Hospital
See details and how to joinNCT05067348 - Korai 1. fázisNot yet taking people in KínaUCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 18
- Run by
- Zhejiang University
See details and how to joinNCT06933563 - 1. fázisNot yet taking people in KínaAn Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Chongbo Zhao
See details and how to joinNCT06759948 - Korai 1. fázisNot yet taking people in KínaUniversal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06485232 - Korai 1. fázisTaking peopleSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT04561557 - No phaseTaking peopleMyasthenia Gravis Registry in China
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Nanchang, Shanghai, Suzhou, Tianjin, Xi’an, Xuzhou, Zhengzhou
- People
- 1500
- Run by
- Huashan Hospital
See details and how to joinNCT06241521